Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus

The MEIA demonstrated acceptable analytical characteristics for use for routine monitoring of sirolimus immunosuppressive therapy, and is a viable alternative to HPLC-based methods for sirolimus monitoring.